Home > Insider Trading > Filing (0001181431-12-055028)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001233	Sangamo Biosciences Inc	SGMO	Biological Products, (No Disgnostic Substances) (2836)	680359556

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1343543	D Philip Gregory	C/O Sangamo Biosciences Inc. Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804	Vp, Therapeutic Dev. & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-10-17	6,000	$4.92	56,000	No	4	M	Direct
Common Stock	Disposition	2012-10-17	6,000	$6.00	50,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-10-17	6,000	$0.00	6,000	$4.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,000		2013-12-02	No	4	M	Direct

Footnotes

Includes 50,000 shares subject to Restricted Stock Units, which will vest 33 1/3% after the completion of two years of service by the Reporting Person measured from the grant date and the remainder will vest after the completion of one year of service thereafter.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2012.
All shares underlying these options have been vested and are exercisable immediately